| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Molecular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871; and 2 National Kinki Chuou Hospital for Chest Disease, Sakai, Osaka 591-8555, Japan
To elucidate the pathophysiology of
pulmonary fibrosis, we investigated the involvement of p38
mitogen-activated protein kinase (MAPK), which is one of the major
signal transduction pathways of proinflammatory cytokines, in a murine
model of bleomycin-induced lung fibrosis. p38 MAPK and its substrate,
activating transcription factor (ATF)-2, in bronchoalveolar lavage
fluid cells were phosphorylated by intratracheal exposure of bleomycin,
and the phosphorylation of ATF-2 was inhibited by subcutaneous
administration of a specific inhibitor of p38 MAPK, FR-167653.
FR-167653 also inhibited augmented expression of tumor necrosis factor
-
, connective tissue growth factor, and apoptosis of lung
cells induced by bleomycin administration. Moreover, daily subcutaneous
administration of FR-167653 (from 1 day before to 14 days after
bleomycin administration) ameliorated pulmonary fibrosis and pulmonary
cachexia induced by bleomycin. These findings demonstrated that p38
MAPK is involved in bleomycin-induced pulmonary fibrosis, and its
inhibitor, FR-167653, may be a feasible therapeutic agent.
phosphorylation of p38 mitogen-activated protein kinase; tumor
necrosis factor-; connective tissue growth factor; antiapoptotic
effect
This article has been cited by other articles:
|
|
 |
|
  M. Nishida, Y. Okumura, H. Sato, and K. Hamaoka Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2520 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Phan Biology of Fibroblasts and Myofibroblasts Proceedings of the ATS, April 15, 2008; 5(3): 334 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Liu, R. R. Warburton, O. E. Guevara, N. S. Hill, B. L. Fanburg, M. Gaestel, and U. S. Kayyali Lack of MK2 Inhibits Myofibroblast Formation and Exacerbates Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 507 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Avivi-Green, M. Singal, and W. F. Vogel Discoidin Domain Receptor 1-deficient Mice Are Resistant to Bleomycin-induced Lung Fibrosis Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 420 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xia, M. T. Longaker, and G. P. Yang P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R501 - R508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Matsuyama, M. Watanabe, Y. Shirahama, R. Hirano, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura Suppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung Inflammation J. Immunol., February 1, 2006; 176(3): 1928 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Matsuyama, M. Watanabe, Y. Shirahama, K.-i. Oonakahara, I. Higashimoto, T. Yoshimura, M. Osame, and K. Arimura Activation of Discoidin Domain Receptor 1 on CD14-Positive Bronchoalveolar Lavage Fluid Cells Induces Chemokine Production in Idiopathic Pulmonary Fibrosis J. Immunol., May 15, 2005; 174(10): 6490 - 6498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Miyazaki, K Kuwano, K Yoshida, T Maeyama, M Yoshimi, M Fujita, N Hagimoto, R Yoshida, and Y Nakanishi The perforin mediated apoptotic pathway in lung injury and fibrosis J. Clin. Pathol., December 1, 2004; 57(12): 1292 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, R. Shu, G. Filippatos, and B. D. Uhal Apoptosis in lung injury and remodeling J Appl Physiol, October 1, 2004; 97(4): 1535 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Inoshima, K. Kuwano, N. Hamada, M. Yoshimi, T. Maeyama, N. Hagimoto, Y. Nakanishi, and N. Hara Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L727 - L733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stambe, D. J. Nikolic-Paterson, P. A. Hill, J. Dowling, and R. C. Atkins p38 Mitogen-Activated Protein Kinase Activation and Cell Localization in Human Glomerulonephritis: Correlation with Renal Injury J. Am. Soc. Nephrol., February 1, 2004; 15(2): 326 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stambe, R. C. Atkins, G. H. Tesch, T. Masaki, G. F. Schreiner, and D. J. Nikolic-Paterson The Role of p38{alpha} Mitogen-Activated Protein Kinase Activation in Renal Fibrosis J. Am. Soc. Nephrol., February 1, 2004; 15(2): 370 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF]
|
|
|
|
|
|
A. B. Rice, J. L. Ingram, and J. C. Bonner p38 Mitogen-Activated Protein Kinase Regulates Growth Factor-Induced Mitogenesis of Rat Pulmonary Myofibroblasts Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 759 - 765. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
